[Sparteine differentiation of vascular effects of adrenalin and noradrenalin reversed or diminished by adrenolytic drugs (883F, 933F; tolazoline, phenotalamine, azapetine, dibenzyline)].
D018674:Adrenergic Antagonists; D002454:Cell Differentiation; D003984:Dibenzazepines; D004837:Epinephrine / Q000494:pharmacology*; D006801:Humans; D006973:Hypertension; D009638:Norepinephrine / Q000494:pharmacology*; D010643:Phenoxybenzamine; D013034:Sparteine / Q000494:pharmacology*; D013565:Sympatholytics; D014043:Tolazoline
D018674:Adrenergic Antagonists; D003984:Dibenzazepines; D013565:Sympatholytics; D010643:Phenoxybenzamine; D013034:Sparteine; C004448:azapetine; D014043:Tolazoline; D009638:Norepinephrine; D004837:Epinephrine
ARTERENOL/effects; EPINEPHRINE/effects; HYPERTENSION/experimental; SPARTEINE/effects; SYMPATHOLYTICS/effects
Différenciation par la spartéine des effets vasculaires de l'adrénaline et de la noradrénaline inversés ou diminués par des adrénolytiques (883 F. 933 F. tolazoline, phentolamine, Azapetine, dibenzyline).